Header Logo

Connection

Naoko Takebe to Imidazoles

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Imidazoles.
Naoko Takebe
Connection Strength
0.060
Imidazoles
  1. PIK3CB Inhibitor GSK2636771 in Cancers With PTEN Mutation/Deletion or Loss of PTEN Protein Expression: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols N and P. JCO Precis Oncol. 2025 Aug; 9:e2500265.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.